Palovarotene Capsule — FDA Drug Shortage

To Be Discontinued — Ipsen Biopharmaceuticals, Inc.

The FDA lists a drug shortage record for Palovarotene Capsule (capsule) from Ipsen Biopharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on Aug 31, 2026.

Shortage details

Status
To Be Discontinued
Company
Ipsen Biopharmaceuticals, Inc.
Package NDC
15054-0025-1
Dosage Form
Capsule
Presentation
SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)
Initial Posting
Aug 31, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.